Instrument Inactif

Communiqués Genentech, Inc.

Actions

DNA

US3687104063

Produits pharmaceutiques

Cours en clôture NYSE
- ^USD	-

12/04/16	Roche: la FDA homologue Venetoclax pour traiter une sorte de leucémie	AW
30/11/-1	Genentech : accroît de 7% son résultat net trimestriel.

Communiqués

20/04/11	Genentech, Inc. : Dalradian Appoints Chief Operating Officer	PU
20/04/11	Genentech, Inc. : Dalradian Appoints Chief Operating Officer	PU
30/11/-1	GENENTECH : Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash	PR
30/11/-1	Genentech : Genentech Announces Resubmission of Supplemental Biologics License Application for Avastin in Combination with Paclitaxel for First-Line Metastatic Breast Cancer	BU
30/11/-1	Genentech : CORRECTING and REPLACING Genentech Announces Expiration of Hart-Scott-Rodino Waiting Period and Completes Acquisition of Tanox	BU
30/11/-1	Genentech : Genentech Announces Second Quarter 2007 Results	BU
30/11/-1	Genentech : Genentech Announces July 11 Webcast Discussion of Earnings and Other Business Results	BU
30/11/-1	Genentech : Updated Overall Survival Data From Pivotal Herceptin Adjuvant Studies in HER2-Positive Breast Cancer	BU
30/11/-1	Genentech : Genentech Provides Update on Pipeline Agents at the American Society of Clinical Oncology Meeting	BU
30/11/-1	Genentech : Phase III Study Shows Avastin Plus Interferon Therapy Nearly Doubled Median Progression-Free Survival in Patients With Previously Untreated Advanced Kidney Cancer	BU
30/11/-1	Genentech : Second Phase III Study of Avastin Plus Chemotherapy Shows Improved Progression-Free Survival in First-Line Non-Squamous, Non-Small Cell Lung Cancer	BU
30/11/-1	Genentech : Genentech Announces June 4 Webcast Discussion of Data Presented at ASCO	BU
30/11/-1	Genentech : Rituxan(R) Phase II Data in Patients with Relapsing-Remitting Multiple Sclerosis Presented at the American Academy of Neurology	BU
30/11/-1	Genentech : Genentech Extends Stock Repurchase Program	BU
30/11/-1	Genentech : Genentech Announces First Quarter 2007 Results	BU
30/11/-1	Genentech : Genentech to Provide Business Update at Annual Investment Community Meeting	BU
30/11/-1	Genentech : Genentech Announces April 11 Webcast Discussion of Earnings and Other Business Results	BU
30/11/-1	Genentech : Genentech Announces March 23 Webcast of Investment Community Meeting	BU
30/11/-1	GENENTECH : Roche Completes Acquisition of Genentech	PR
30/11/-1	GENENTECH : Roche Completes Tender Offer for Genentech	PR
30/11/-1	GENENTECH : Roche and Genentech Reach a Friendly Agreement to Combine the Two Organizations and Create a Leader in Healthcare Innovation	PR
30/11/-1	GENENTECH : Roche Increases Offer Price for Genentech Shares to US$ 93.00 per Share and Extends Offer	PR